US Government Stake Speculation IonQ Micron and Anduril Emerge as Potential Targets After Quantum Investments International Students Face Growing Barriers to US Employment as Hiring Market Weakens and Immigration Rules Tighten Q4 Earnings Season Updates EID Parry Reports Loss Marksans Pharma and Astra Microwave See Profit Gains US Productivity Growth Slows in Q4 as Unit Labor Costs Rise Signaling Potential Inflationary Pressures Zscaler Shares Slide 24 Premarket Following Cautious FullYear Guidance DeepSeek Fears Overblown US AI Giants May Weather the Storm CVCO Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Gains 36 ARHS Q1 2026 Earnings EPS Surprises to the Upside Amidst Challenging Retail Environment IAC Q1 2026 Earnings Steep EPS Miss Overshadowed by Modest Stock Gain BFRI Q1 2026 Earnings Wide EPS Miss Fails to Dampen Investor Sentiment Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Stock Gains Slightly Vistance Networks Inc VISN Q1 2026 Earnings EPS Surges Past Estimates with 7094 Surprise Gladstone Land Preferred Stock LANDO Slips Testing Key Support Levels Manhattan Bridge Capital LOAN Holds Steady Near MidRange Despite Low Volume BT Brands Inc BTBD Holds Steady Near Support After Modest Gain Crown Castle CCI Slips 06 as Telecom REIT Tests Key Support Zone Hercules Capital 625 Notes HCXY Edge Higher Amid Stable Credit Conditions Crypto Traders Eye Key US Economic Data PCE Jobless Claims and GDP Revision in Focus GBLI Q1 2026 Earnings Significant EPS Miss Underscores Underwriting Challenges Assembly Biosciences ASMB Slides 386 as Biotech Sector Faces Headwinds WTFCN Q1 2026 Earnings EPS Surpasses Estimates by 613 Stock Holds Steady CCAP Q1 2026 Earnings Slight EPS Miss Amidst Stable Portfolio Performance Eagle Bancorp Montana Inc EBMT Q1 2026 Earnings EPS Beat Boosts Investor Sentiment JOE Q1 2026 Earnings Profitability Maintained on Modest EPS Stock Edges Higher ASPI Q4 2025 Earnings Massive EPS Shortfall but Stock Surges as Market Focuses on Pipeline Progress AVXL Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances MESO Q1 2026 Earnings EPS Miss Amid Ongoing Pipeline Progress